Can mindfulness ease psychosis in teens and young adults?

NCT ID NCT07645443

Recruiting now Symptom relief Sponsor: Stephanie Mehl Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This study tests whether a 4-week mindfulness group therapy program, added to usual care, can reduce symptoms in 252 young people (ages 16-35) hospitalized for early psychosis. Participants are randomly assigned to either the mindfulness program plus standard treatment or standard treatment alone. The main goal is to see if mindfulness helps lower overall psychiatric symptoms after 4 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mindfulness-based group therapy
What this could lead to: If it works, this could offer a new, drug-free way to help young people manage psychosis symptoms during hospitalization.
What could go wrong: This is an early-stage trial with no phase, so results are uncertain. The therapy is added to standard care, so any benefit may be small or hard to separate from usual treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRIEF PSYCHOTIC DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delusional disorder early-onset schizophrenia Emotional Regulation paranoid schizophrenia psychiatric disorder psychotic disorder Psychotic Disorders schizophrenia schizophreniform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRIEF PSYCHOTIC DISORDER DELUSIONAL DISORDER EARLY ONSET PSYCHOSIS FIRST EPISODE PSYCHOSIS FIRST PSYCHOTIC EPISODE WITHIN THE LAST 5 YEARS OTHER PSYCHOTIC DISORDER NOT DUE TO A SUBSTANCE OR KNOWN PHYSIOLOGICAL CONDITION PSYCHOSIS PSYCHOSIS NOS RANDOMIZED CONTROLLED TRIAL (RCT) SCHIZOPHRENIA / SCHIZOAFFECTIVE DISORDER SCHIZOPHRENIA SPECTRUM DISORDERS (SSD) SCHIZOPHRENIFORM DISORDER

Contacts and locations

Locations

Charité-Universitätsmedizin Berlin (CCM), Department of Psychiatry and Psychotherapy, , Charitéplatz 1, D-10117 Berlin, Germany
RECRUITING

Berlin, State of Berlin, 10117, Germany
Ludwig-Maximilians Universität Munich, Department of Psychiatry and Psychotherapy, Nussbaumstr. 7, 80336 Munich
RECRUITING

München, Bavaria, 80336, Germany
Marburg University, Department of Psychiatry and Psychotherapy, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany
RECRUITING

Marburg, Hesse, 35039, Germany
University of Augsburg, Department of Psychiatry and Psychotherapy, Geschwister-Schoenert-Str. 1, 86156 Augsburg
RECRUITING

Augsburg, Bavaria, 86156, Germany
University of Cologne, Department of Psychiatry and Psychotherapy, Kerpener Str. 62, 50937 Cologne
RECRUITING

Cologne, North Rhine-Westphalia, 50937, Germany
University of Hamburg, Universitätsklinikum Hamburg-Eppendorf Hamburg, Department of Psychiatry and Psychotherapy
RECRUITING

Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany
University of Mannheim, Central Institute of Mental Health, Department of Psychiatry and Psychotherapy, J5, 68169 Mannheim
RECRUITING

Mannheim, Baden-Wurttemberg, 68159, Germany
Vivantes Klinikum am Urban, Hospital for Psychiatry, Psychotherapy und Psychosomatics, Dieffenbachstr. 1, 10967 Berlin
RECRUITING

Berlin, State of Berlin, 10967, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.